I have spent the bulk of my professional career writing and creating in the oncology and hematology arena.  From the strategy through execution, this work spans my entire career.  These brands include: 

Tafinlar and Mekinist for metastatic melanoma

TEVA Biosimilars Oncology Francise (Herzuma, Truxima)

Revlimid, an immunomodulatory agent fos multiple myeloma.

VITRAKVI, targed therapy for solid tumors (cancer) caused by NTRK genes

Arzerra, a monocolonal antibody for chronic lymphocytic leukemia

Bexxar, a radiolabeled monoclonal antibody for non-Hodgkin's lymphoma

Hycamtin for ovarian cancer and small cell lung cancer

Navelbine, for breast cancer

Argatroban, for heparin-induced thrombocytopenia